Pharmaceuticals, Biotechnology and Life Sciences
This milestone makes esketamine nasal spray the first N-methyl-D-aspartate (NMDA) antagonist to be approved for patients with Major Depressive Disorder…
ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at…
CHICAGO–(BUSINESS WIRE)–#AI–Dr. Steve Steinhubl, a leader in reinventing medicine through the convergence of healthcare and technology and an expert in…
CHICAGO–(BUSINESS WIRE)–#AI–Dr. Steve Steinhubl, a leader in reinventing medicine through the convergence of healthcare and technology and an expert in…
CHICAGO–(BUSINESS WIRE)–#AI–Dr. Steve Steinhubl, a leader in reinventing medicine through the convergence of healthcare and technology and an expert in…
RESEARCH TRIANGLE PARK, N.C. & MALMÖ, Sweden–(BUSINESS WIRE)–Trialbee, a leading global technology provider for patient matching and engagement in clinical…
RESEARCH TRIANGLE PARK, N.C. & MALMÖ, Sweden–(BUSINESS WIRE)–Trialbee, a leading global technology provider for patient matching and engagement in clinical…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–#BoardAppointments—Imago BioSciences, Inc. (Imago), a clinical stage biopharmaceutical company developing innovative treatments for myeloid diseases, today…
RESEARCH TRIANGLE PARK, N.C. & MALMÖ, Sweden–(BUSINESS WIRE)–Trialbee, a leading global technology provider for patient matching and engagement in clinical…
TOKYO & MUNICH & BASKING RIDGE, N.J. & NASHVILLE, Tenn.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Sarah Cannon…